BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28053086)

  • 21. Discoidin Domain Receptor 1 Mediates Myosin-Dependent Collagen Contraction.
    Coelho NM; Arora PD; van Putten S; Boo S; Petrovic P; Lin AX; Hinz B; McCulloch CA
    Cell Rep; 2017 Feb; 18(7):1774-1790. PubMed ID: 28199848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential role of nonmuscle myosin II isoforms during blebbing of MCF-7 cells.
    Dey SK; Singh RK; Chattoraj S; Saha S; Das A; Bhattacharyya K; Sengupta K; Sen S; Jana SS
    Mol Biol Cell; 2017 Apr; 28(8):1034-1042. PubMed ID: 28251924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratin 5-Cre-driven excision of nonmuscle myosin IIA in early embryo trophectoderm leads to placenta defects and embryonic lethality.
    Crish J; Conti MA; Sakai T; Adelstein RS; Egelhoff TT
    Dev Biol; 2013 Oct; 382(1):136-48. PubMed ID: 23911870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
    Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
    Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tumor suppressor Lgl1 forms discrete complexes with NMII-A and Par6α-aPKCζ that are affected by Lgl1 phosphorylation.
    Dahan I; Petrov D; Cohen-Kfir E; Ravid S
    J Cell Sci; 2014 Jan; 127(Pt 2):295-304. PubMed ID: 24213535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor suppressor Lgl1 regulates front-rear polarity of migrating cells.
    Ravid S
    Cell Adh Migr; 2014; 8(4):378-83. PubMed ID: 25482644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of cortical myosin phosphorylation by p114RhoGEF drives cell migration and tumor cell invasion.
    Terry SJ; Elbediwy A; Zihni C; Harris AR; Bailly M; Charras GT; Balda MS; Matter K
    PLoS One; 2012; 7(11):e50188. PubMed ID: 23185572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmuscle myosin IIA is associated with poor prognosis of esophageal squamous cancer.
    Xia ZK; Yuan YC; Yin N; Yin BL; Tan ZP; Hu YR
    Dis Esophagus; 2012 Jul; 25(5):427-36. PubMed ID: 21951916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic acid matrices show matrix stiffness in 2D and 3D dictates cytoskeletal order and myosin-II phosphorylation within stem cells.
    Rehfeldt F; Brown AE; Raab M; Cai S; Zajac AL; Zemel A; Discher DE
    Integr Biol (Camb); 2012 Apr; 4(4):422-30. PubMed ID: 22344328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A proteomic study of myosin II motor proteins during tumor cell migration.
    Betapudi V; Gokulrangan G; Chance MR; Egelhoff TT
    J Mol Biol; 2011 Apr; 407(5):673-86. PubMed ID: 21316371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of a role for nonmuscle myosin II in herpes simplex virus type 1 egress.
    van Leeuwen H; Elliott G; O'Hare P
    J Virol; 2002 Apr; 76(7):3471-81. PubMed ID: 11884571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel regulation and dynamics of myosin II activation during epidermal wound responses.
    Betapudi V; Rai V; Beach JR; Egelhoff T
    Exp Cell Res; 2010 Apr; 316(6):980-91. PubMed ID: 20132815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LIMCH1 regulates nonmuscle myosin-II activity and suppresses cell migration.
    Lin YH; Zhen YY; Chien KY; Lee IC; Lin WC; Chen MY; Pai LM
    Mol Biol Cell; 2017 Apr; 28(8):1054-1065. PubMed ID: 28228547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-muscle myosin II isoforms orchestrate substrate stiffness sensing to promote cancer cell contractility and migration.
    Peng Y; Chen Z; He Y; Li P; Chen Y; Chen X; Jiang Y; Qin X; Li S; Li T; Wu C; Yang H; You F; Liu Y
    Cancer Lett; 2022 Jan; 524():245-258. PubMed ID: 34715250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk.
    Even-Ram S; Doyle AD; Conti MA; Matsumoto K; Adelstein RS; Yamada KM
    Nat Cell Biol; 2007 Mar; 9(3):299-309. PubMed ID: 17310241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonmuscle myosin IIA and IIB differentially modulate migration and alter gene expression in primary mouse tumorigenic cells.
    Halder D; Saha S; Singh RK; Ghosh I; Mallick D; Dey SK; Ghosh A; Das BB; Ghosh S; Jana SS
    Mol Biol Cell; 2019 Jun; 30(12):1463-1476. PubMed ID: 30995168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presenilin/γ-secretase-dependent EphA3 processing mediates axon elongation through non-muscle myosin IIA.
    Javier-Torrent M; Marco S; Rocandio D; Pons-Vizcarra M; Janes PW; Lackmann M; Egea J; Saura CA
    Elife; 2019 Oct; 8():. PubMed ID: 31577226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motility.
    Hosono Y; Usukura J; Yamaguchi T; Yanagisawa K; Suzuki M; Takahashi T
    Biochem Biophys Res Commun; 2012 Nov; 428(1):173-8. PubMed ID: 23068101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Of mice and men: Relevance of cellular and molecular characterizations of myosin IIA to MYH9-related human disease.
    Even-Ram S; Yamada KM
    Cell Adh Migr; 2007; 1(3):152-5. PubMed ID: 19262128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmuscle myosin IIA and IIB differently suppress microtubule growth to stabilize cell morphology.
    Sato Y; Kamijo K; Tsutsumi M; Murakami Y; Takahashi M
    J Biochem; 2020 Jan; 167(1):25-39. PubMed ID: 31599953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.